Ulrika Tehler

Optimizing Solubility and Permeability of a Biopharmaceutics Classification System (BCS) Class 4 Antibiotic Drug Using Lipophilic Fragments Disturbing the Crystal Lattice

Ulrika Tehler, Jonas H. Fagerberg, Richard Svensson et al. · Journal of Medicinal Chemistry · 2013 · 55 citations

Pharmaceutical Formulation, Medicinal Chemistry, Drug Analysis +15

Selective Nonsteroidal Glucocorticoid Receptor Modulators for the Inhaled Treatment of Pulmonary Diseases

Martin Hemmerling, Stinabritt Nilsson, K. A. P. Edman et al. · Journal of Medicinal Chemistry · 2017 · 54 citations · Full text

Asthma, Inflammatory Lung Disease, Lung Inflammation +20

Hyaluronic Acid Hydrogels for Controlled Pulmonary Drug Delivery—A Particle Engineering Approach

Dariush Nikjoo, Irès van der Zwaan, Mikael Brűlls et al. · Pharmaceutics · 2021 · 51 citations · Full text

Biopolymer Gel, Hydrogels, Hydrogels Warrant Attention +12

Predicting Exposure After Oral Inhalation of the Selective Glucocorticoid Receptor Modulator, AZD5423, Based on Dose, Deposition Pattern, and Mechanistic Modeling of Pulmonary Disposition

Per Bäckman, Ulrika Tehler, Bo Olsson · Journal of Aerosol Medicine and Pulmonary Drug Delivery · 2016 · 35 citations

Ranking in Vitro Dissolution of Inhaled Micronized Drug Powders including a Candidate Drug with Two Different Particle Sizes

Frans Franek, Rebecca Fransson, Helena Thörn et al. · Molecular Pharmaceutics · 2018 · 24 citations